Conférenciers invités

La venue de plusieurs conférenciers invités de renom est d'ores et déjà confirmée:

Young Hae Choi de l’Université de Leiden


Prof. Young Hae Choi ( is currently working in Natural Products Laboratory, Institute of Biology, Leiden University (Leiden, the Netherlands) as group leader. He graduated College of Pharmacy, Seoul National University in 1992. In 2000, he received PhD diploma from the same university. After a two year-post-doc experience, he moved to Leiden University. Since then, he has devoted himself to develop a quantitative and qualitative NMR spectroscopic method for the analysis of plant and microbial secondary metabolites in mixtures as a robust metabolomics tool. Currently, he is interested in several research topics related to natural products such as ‘plant metabolomics for the purpose of horticulture, agriculture and medicinal plants’, ‘plant-microbial chemical interaction for symbiotic cooperation against plant pathogens’, ‘investigation of natural deep eutectic solvents in plant cells and their application to green chemistry’, ‘development of biopesticides from plants’.


Christine Des Rosiers du l'institut de cardiologie de Montréal


Dr. Christine Des Rosiers is a Professor in the Department of Nutrition of the Université de Montréal and Director of the Montreal Heart Institute Research Centre Metabolomic Laboratory and Platform.  She is a founding member of the Society for Heart and Vascular Metabolism and is currently serving as President since 2015. The focus of her research is on the role of metabolic alterations in the pathogenesis of disease, particularly heart disease. She has over 25 years of research experience in metabolic investigations using stable isotopes and mass spectrometric-based methodology. She specifically gained recognition for the development of these methods for the metabolic and functional phenotyping of the ex vivo working mouse heart. More recently, she has taken the direction of metabolomic initiatives as part of multidisciplinary translational projects aiming at the discovery of biomarkers of disease development or treatment response in various conditions, which include heart disease, but also diabetes, as well as mitochondrial and inflammatory diseases.


Bénedicte Elena de l’ISA (Institut des Sciences Analytiques) de Lyon


Bénédicte Elena-Herrmann completed her Ph.D. in Chemistry at the Ecole Normale Supérieure in Lyon, France, where she developed high-resolution proton NMR spectroscopy in the solid-state and NMR powder crystallography under the supervision of Lyndon Emsley. During her thesis, she spent a year at the University of California, Berkeley, in the group of Alex Pines working on fundamental NMR methodology. In 2005, she joined as a CNRS scientist the project team for the European High-Field NMR Centre in Lyon that opened its doors in 2008 as a high-end large scale infrastructure for NMR and welcomed in 2009 the first 1 GHz NMR spectrometer world-wide. Meanwhile, she developed HR-MAS NMR approaches for whole organism metabolomic studies of intact model systems for functional genomics applications. Since then, she has established a research group at the Institute for Analytical Sciences in Lyon that focus on NMR metabolomics developments for biomedical research. She has notably conducted a number of translational and prospective clinical metabolomic investigations on cancer. In 2018, she integrates the Institute for Advanced Biosciences in Grenoble, France.


Jules Griffin de l’Université de Cambridge


Prof. Jules Griffin ( is currently senior lecturer in the department of Biochemistry of the University of Cambridge. He is also honorary professor at the imperial college of London and a fellow of king’s college in Cambridge. He studied at the University of Oxford and was awarded a 1st Class degree in Chemistry and then a D.Phil. in Biochemistry and prior to his move to Cambridge, he held posts at Harvard Medical School (1997-9) and Imperial College London (1999-2003), and was a Royal Society University Research Fellow at Imperial College London (2000-3) and the University of Cambridge (2003-8). The aim of its research group, in conjunction with the Lipid Profiling and Signalling group at MRC Human Nutrition Research, is to understand the regulation of lipid metabolism and its interplay with health and diseases of over nutrition. The Griffin group is also actively involved in the designing of bioinformatic and database tools for metabolomics and lipidomics.


Serge Rudaz de l’Université de Genève


Serge Rudaz is Associate Professor at the University of Geneva. Research group leader and member of the management Board of the Swiss Centre for Applied Human Toxicology (SCAHT) Foundation, he’s is also President of the Competence Center in Chemical and Toxicological Analysis (ccCTA) and President of the Swiss Metabolomics Society (SMS). He is interested in metabolomics, (UHP)LC and CE coupled to MS, advances in sample preparation, analysis of pharmaceuticals and counterfeits medicines, biological matrices, clinical and preclinical studies, including metabolism and toxicological analysis. Serge Rudaz is an expert in various chemometric approaches, including experimental design (DOE), validation and regulation (ISO17025) as well as multivariate data analysis (MVA) for metabolomics. He published numerous scientific papers.


Personnes connectées : 1